Terbinafine
Amykal, Lamisil, Lamisilonce, Myconormin · ATC code D01AE15
Also known as: Terbinafin · Brand names: Amykal, Lamisil, Lamisilonce, Myconormin, Terbiderm, Terbinafin Genericon, Terbinafin Ratiopharm, Fungizid Extra, Lamsil, Terbigalen, Terbinafinhydrochlorid Al, Terbinafinhydrochlorid Stada, Corbinal, Erbinol %, Laminox % …
- Key facts
- Active substance
- Terbinafine
- ATC code
- D01AE15
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Terbinafine is an oral antifungal. According to the US prescribing information, it is used to treat onychomycosis of the toenail or fingernail caused by dermatophytes (tinea unguium).
What it is used for
- Onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium)
- The diagnosis should be confirmed by nail specimens (KOH preparation, fungal culture or nail biopsy) before treatment
Dosing
- Before starting: evaluate for chronic or active liver disease
- Fingernail onychomycosis: one 250 mg tablet once daily for 6 weeks
- Toenail onychomycosis: one 250 mg tablet once daily for 12 weeks
- The optimal clinical effect is seen some months after mycological cure, reflecting outgrowth of healthy nail
Contraindications
- History of allergic reaction to oral terbinafine (risk of anaphylaxis)
- Chronic or active liver disease
Important warnings
- Hepatotoxicity: liver failure, some cases leading to liver transplant or death, including in patients without preexisting liver disease; liver function tests before treatment and periodic monitoring recommended
- Persistent nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine or pale stools: stop treatment and evaluate liver function
- Taste and smell disturbance, including loss, which may be prolonged or permanent; discontinue if symptoms occur
- Depressive symptoms reported postmarketing
- Transient decreases in lymphocyte counts and cases of severe neutropenia; consider blood counts in immunodeficient patients
- Serious skin/hypersensitivity reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS) and precipitation or exacerbation of lupus erythematosus
Side effects
- Most frequent: gastrointestinal symptoms (diarrhea, dyspepsia, abdominal pain)
- Liver test abnormalities
- Rash, urticaria, pruritus
- Taste disturbance
- Changes in the ocular lens and retina reported (clinical significance unknown)
- Events were generally mild and transient
Interactions
- Terbinafine inhibits CYP2D6: careful monitoring and possibly dose reduction of CYP2D6-metabolized drugs (e.g. tricyclic antidepressants, SSRIs, beta-blockers, class 1C antiarrhythmics such as flecainide and propafenone, MAO type B inhibitors)
- With desipramine, Cmax and AUC rose markedly, and the effect persisted for weeks after terbinafine was stopped
Pregnancy and breastfeeding
- Pregnancy: available data are insufficient to evaluate a drug-associated risk; no malformations in animal studies
- Lactation: terbinafine is present in human milk; no data on effects on the breastfed child
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- AmykalPelpharma Handels Gmbh · 2 register entries
- LamisilKaro Healthcare Ab, Moberg Pharma Ab · 2 register entries
- LamisilonceKaro Healthcare Ab · 1 register entry
- MyconorminAlmirall Hermal Gmbh · 1 register entry
- TerbidermDermapharm Gmbh · 1 register entry
- Terbinafin GenericonGenericon Pharma Gesellschaft M.B.H. · 1 register entry
- Terbinafin RatiopharmTeva B.V · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- Fungizid ExtraRatiopharm Gmbh · 1 register entry
- LamisilKaro Healthcare Ab · 2 register entries
- LamsilKaro Healthcare Ab · 1 register entry
- MyconorminAlmirall Hermal Gmbh · 1 register entry
- TerbidermDermapharm Ag · 3 register entries
- TerbigalenGalenpharma Gmbh · 1 register entry
- Terbinafin1 A Pharma Gmbh, Ratiopharm Gmbh, Puren Pharma Gmbh & Co. Kg, Scholl’s Wellness Company B.V, Heumann Pharma Gmbh & Co. Generica Kg, Abcnow Gmbh, Teva Gmbh, Abz-Pharma Gmbh, Aliud Pharma Gmbh · 12 register entries
- Terbinafinhydrochlorid AlAliud Pharma Gmbh · 1 register entry
- Terbinafinhydrochlorid StadaStada Consumer Health Deutschland Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- CorbinalBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- Erbinol %WORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- Laminox %ORBİS PHARMA İLAÇ VE KİMYA KOZMETİK MEDİKAL SAN. TİC. LTD. ŞTİ. · 3 register entries
- MikonafinUMUT İLAÇ TİC. VE SAN. LTD. ŞTİ. · 3 register entries
- MycocurNOBEL İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- MyconafKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 1 register entry
- TekfinDEVA HOLDİNG A.Ş. · 3 register entries
- TerbifortHAKAY İLAÇ PAZARLAMA SAN. VE TİC. LTD. ŞTİ. · 2 register entries
- TerbinAVİXA İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- TerbisilSANTA FARMA İLAÇ SAN. A.Ş. · 3 register entries
- TerbonileBİLİM İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- TerminusRECORDATİ İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
Show all 14 brand names
- TermycetHUMANİS SAĞLIK A.Ş. · 3 register entries
- TigalSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 27 more European countries
- Belgium
- Lamisil, Terbinafin Ab, Terbinafine Eg, Terbinafine Sandoz, Terbinafine Teva, Terbinafine Viatris
- Bulgaria
- Exoterbyn, Ербинол, Ламизил, Миконафин, Тербинафин Генерикон, Фунгитер, Фунгофин
- Croatia
- Atere, Exoterbyn, Lamisil, Terbinax
- Cyprus
- Chemiderm, Fungifex, Medofloran
- Czechia
- Lamisil, Terbinafin Moberg Pharma, Terbinafin Sandoz, Terbinafin Teva, Terbistad, Terfimed
- Denmark
- Finigen, Lamisil, Onychosil, Terbinafin Actavis, Terbinafin Hexal, Terbinafin Medical Valley, Terbistad, Terclara
- Estonia
- Exotafin, Lamisil, Terbinafin Actavis, Terbinafin Ratiopharm, Terbinafine Olpha, Terbinafine Sandoz
- Finland
- Fungorin, Lamisil, Onychosil, Terbinafin Hexal, Terbinafin Ratiopharm, Terbinafin Sandoz, Terbistada, Terclara
- France
- Fungster, Lamisil, Lamisilate, Lamisildermgel, Terbinafine Almus, Terbinafine Arrow, Terbinafine Biogaran, Terbinafine Cristers, Terbinafine Eg, Terbinafine Evolugen, Terbinafine Moberg Pharma, Terbinafine Sandoz, Terbinafine Teva, Terbinafine Viatris, Terbinafine Zentiva, Terbinafine Zydus
- Greece
- Anaplas, Chemiderm, Demsil, Frezylin, Lamisil, Pavlinox, Soluterb, Teranfis, Terbafin, Terbin, Terbinafine Target, Terbinafine Τοπικό Αντιμυκητιασικό Φάρμακο Target, Terbiprol, Terilam, Zakofin
- Hungary
- Exoterbyn, Lamisil Derma, Myconafine, Terbinafin Hexal, Terbinafin Moberg Pharma, Terbinafin Wagner, Terbinafine Q Pharma, Terbiner, Terbisil
- Iceland
- Lamisil, Terbinafin Actavis, Terbinafin Medical Valley
- Ireland
- Fungasil, Lamisil, Nailderm, Terbasil, Terbinafine Rowa, Terbza
- Italy
- Lamisil, Micutan, Onicoter, Pevaonico, Terbinafina Alter, Terbinafina Aurobindo Pharma Italia, Terbinafina Doc Generici, Terbinafina Eg, Terbinafina Hexal, Terbinafina Mylan Generics, Terbinafina Sandoz Gmbh, Terbinafina Tecnigen
- Latvia
- Exotafin, Lamisil, Terbinafin Actavis, Terbinafin Ratiopharm, Terbinafine Olpha
- Lithuania
- Lamisil, Posamyk, Terbinafin Actavis, Terbinafin Ratiopharm
- Luxembourg
- Lamisil
- Malta
- Fungasil, Medofloran, Terbinafine
- Netherlands
- Antischimmelcrème Terbinafine Hcl Htp, Binanidda, Da Antischimmelcrème, Huidschimmelcrème Terbinafine Hcl Etos, Kruidvat, Lamisil Dermgel, Lamisil Huidschimmelcrème, Lamisil Lotion, Lamisil Once, Lamisil Spray, Lamisil Voetschimmelcrème, Livsane Antischimmelcrème Terbinafine Hcl, Niddafin, Terbinafine Aurobindo, Terbinafine Focus, Terbinafine Hcl Antischimmelcrème Sam, Terbinafine Hcl Teva, Terbinafine Sandoz, Terbinafine Viatris, Terbinafine Xiromed, Terbisil
- Norway
- Lamisil, Terbinafin Hexal, Terbinafin Moberg Pharma, Terbinafin Ratiopharm, Terbinafinhydroklorid Norfri Evolan Pharma, Terclara
- Poland
- Erfin, Lamisilatt, Myconafine, Przeciwgrzybiczny Do Stóp, Terbiderm, Terbinafina Ziaja, Tersilat, Undofen Max, Zelefion
- Portugal
- Fungur, Lamisil, Silbiter, Terbinafina, Terbinafine Ratiopharm, Termycol
- Romania
- Exoterfyn, Fungisil Mk, Lamisil, Taficen, Terbinafina Slavia, Terbinafină Arena, Terbinafină Ozone
- Slovakia
- Exoterin, Lamisil, Onychomed, Terbinafin Teva, Terbinafin Viatris
- Slovenia
- Exoter, Lamisil, Terbinafin Viatris
- Spain
- Lamisil, Pevaryl Uñas, Scholmed, Terbinafina Alter, Terbinafina Aurovitas, Terbinafina Combix, Terbinafina Kern Pharma, Terbinafina Normon, Terbinafina Pensa, Terbinafina Viatris
- Sweden
- Azurifin, Lamisil, Terbinafin Abece, Terbinafin Apofri, Terbinafin Medical Valley, Terbinafin Moberg Pharma, Terbinafin Teva, Terbisil, Terclara
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Terbinafine (Cipla USA Inc.) – Prescribing Information, 2025-09-19. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18b16aad-1877-4b07-b532-f0ef4843af91
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.